Company page
Xeno Transplants Corporation
Xeno Transplants Corporation, trading under the ticker XENO, is a public company based in the United States with a market capitalization of approximately $4.04 billion. The company focuses on innovative solutions in the field of organ transplantation. Xeno aims to address the challenges associated with organ shortages and improve patient outcomes through its advanced technologies.

- Ticker
- XENO
- Market cap
- $4,036
- Sector
- Health Technology
- Industry
- Biotechnology